<DOC>
	<DOCNO>NCT00901108</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Trabectome versus Trabeculectomy adjunctive Mitomycin C , combine cataract surgery , patient open angle glaucoma .</brief_summary>
	<brief_title>Trabectome Versus Trabeculectomy With Mitomycin C Patients With Open Angle Glaucoma</brief_title>
	<detailed_description>Background : Trabeculectomy adjunctive use Mitomycin C ( Trab MMC ) standard incisional procedure lower intraocular pressure ( IOP ) adult open angle glaucoma ( OAG ) . Trab MMC show effectively low IOP , however , associate number serious complication , hypotony maculopathy , choroidal effusion hemorrhage , endophthalmitis , well less serious complication may affect vision relate quality life bleb dysesthesia . A new technology , refer Trabectome ( NeoMedix Corp. , San Juan Capistrano , CA ) , remove arc trabecular meshwork inner wall Schlemm 's canal microcautery appear low IOP effectively few less serious complication Trab MMC . However , study need determine long term safety efficacy relatively new procedure . In addition , OAG patient visually significant cataract , either Trab MMC Trabectome combine cataract surgery . Study Objective : To compare efficacy safety Trabectome versus Trab MMC , combination cataract extraction phacoemulsification intraocular lens implant , control IOP OAG , include pseudoexfoliative glaucoma . Methods : Single center , single surgeon , prospective randomize controlled trial . A total 52 eligible participant , 26 per study arm would need recruited 90 % power . One eye per study patient enrol randomized Trabectome combine cataract surgery ( Trabectome-IOL ) Trab MMC combine cataract surgery ( Trab-IOL ) . Postoperative visit take place discretion surgeon include least visit day 1 , week 1 , month 1 , 3 , 6 , 12 . Postoperative glaucoma medication add stepped regimen appropriate , along additional laser surgical procedure need . Current Study Status : The clinical trial terminate early due slow recruitment clearer indication technique time lead lack clinical equipoise essential patient randomization/recruitment . This discuss agree upon data safety monitor board . A total 19 participant recruit followup one year . Study analysis pending .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>1 . Age 4085 year 2 . Open angle glaucoma ( include pseudo exfoliative glaucoma ) 3 . Open angle ( â‰¥ Shaffer grade II ) 4 . Inadequately control IOP require surgical intervention 5 . Visually significant cataract 6 . Willing complete quality life questionnaires 7 . Capable informed consent available least 1 year followup 1 . Any form angle closure glaucoma 2 . Secondary open angle glaucoma 3 . Absence clear angle landmark gonioscopy 4 . Other ocular disease may affect assessment visual acuity , visual field , accurate tonometry 5 . Previous angle surgery filter procedure 6 . Steroid use within precede 3 month 7 . Presence significant comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>open angle glaucoma</keyword>
	<keyword>trabectome</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>cataract</keyword>
</DOC>